Edition:
United Kingdom

Fuji Pharma Co Ltd (4554.T)

4554.T on Tokyo Stock Exchange

4,020JPY
17 Nov 2017
Change (% chg)

¥20 (+0.50%)
Prev Close
¥4,000
Open
¥4,015
Day's High
¥4,040
Day's Low
¥3,965
Volume
31,600
Avg. Vol
29,145
52-wk High
¥4,330
52-wk Low
¥2,550

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -- September 18 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 0
(2) OUTPERFORM 1 1 2 2
(3) HOLD 0 0 0 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.67 2.33

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 1 10,084.00 10,084.00 10,084.00 --
Year Ending Sep-17 2 36,550.00 37,000.00 36,100.00 --
Year Ending Sep-18 2 40,250.00 41,500.00 39,000.00 41,700.00
Year Ending Sep-19 2 43,900.00 46,800.00 41,000.00 --
Earnings (per share)
Year Ending Sep-17 2 208.80 213.80 203.80 --
Year Ending Sep-18 2 254.25 264.60 243.90 243.70
Year Ending Sep-19 2 298.35 309.40 287.30 --

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 10,084.00 9,371.00 713.00 7.07
Quarter Ending Jun-14 7,550.00 6,783.00 767.00 10.16
Quarter Ending Mar-14 7,170.00 7,274.00 104.00 1.45

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-17 10,084.00 -- -- -- --
Year Ending Sep-17 36,550.00 -- -- -- --
Year Ending Sep-18 40,250.00 40,250.00 40,250.00 40,100.00 41,700.00
Year Ending Sep-19 43,900.00 43,900.00 43,900.00 43,450.00 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-17 -- -- -- --
Year Ending Sep-17 -- -- -- --
Year Ending Sep-18 0 0 0 0
Year Ending Sep-19 0 0 0 0
Earnings